Christine Turner

Associate
Full contact info

About Christine

Christine’s practice focuses on capital markets transactions. She represents investment banks and late-stage private and public companies in a variety of corporate and securities transactions, including initial public offerings (IPOs), follow-on and secondary offerings, private placements and convertible debt offerings.

Christine’s representative transactions include advising:

  •  Structure Therapeutics in its $185.3 million IPO
  • The underwriters in Arcutis Biotherapeutics’s $172.5 million follow-on offering
  • The underwriters in Apellis Pharmaceuticals’s $402.5 million follow-on offering
  • The underwriters in IGM Biosciences’s $230 million follow-on offering
  • The underwriters in Doximity’s $697 million IPO
  • The underwriters in FIGS’ $668 million IPO
  • The underwriters in Treace Medical Concepts’ $220 million IPO
  • ZoomInfo Technologies in its $1.07 billion IPO*

Christine’s representative private placements include advising:

  • The placement agent in Vertex Energy’s $155 million offering of convertible senior notes
  • The placement agent in Porch Group’s $333.3 million offering of convertible senior notes
  • The placement agent in New Mountain Finance Corporation’s $200 million offering of convertible senior notes

* Representation handled prior to joining Cooley

Before joining Cooley, Christine was a capital markets associate in the New York office of Simpson Thacher & Bartlett. Christine also served as a law clerk to Vice Chancellor Sam Glasscock III on the Delaware Court of Chancery during the 2015 – 2016 term.

While in law school, Christine served as managing editor of the Duke Law Journal.


Education

Duke University School of Law
JD, 2015, cum laude

Boston College
BA, 2010, International Studies, magna cum laude

Memberships and affiliations

New York State Bar Association